Trexquant Investment LP Makes New $9.30 Million Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Trexquant Investment LP purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 17,819 shares of the medical equipment provider’s stock, valued at approximately $9,301,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Geode Capital Management LLC increased its stake in Intuitive Surgical by 3.2% in the fourth quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock worth $4,039,200,000 after purchasing an additional 243,802 shares during the period. National Wealth Management Group LLC purchased a new position in Intuitive Surgical in the 4th quarter worth about $436,000. Nemes Rush Group LLC boosted its position in Intuitive Surgical by 7.2% in the 4th quarter. Nemes Rush Group LLC now owns 344 shares of the medical equipment provider’s stock valued at $180,000 after buying an additional 23 shares during the period. HighPoint Advisor Group LLC boosted its position in Intuitive Surgical by 6.8% in the 4th quarter. HighPoint Advisor Group LLC now owns 5,160 shares of the medical equipment provider’s stock valued at $2,693,000 after buying an additional 327 shares during the period. Finally, B. Metzler seel. Sohn & Co. AG grew its stake in Intuitive Surgical by 2.7% in the 4th quarter. B. Metzler seel. Sohn & Co. AG now owns 20,861 shares of the medical equipment provider’s stock worth $10,889,000 after acquiring an additional 552 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Up 2.2 %

ISRG opened at $507.05 on Thursday. The firm’s 50-day moving average price is $550.11 and its 200-day moving average price is $532.84. The company has a market cap of $180.60 billion, a P/E ratio of 79.10, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 33,754 shares of company stock worth $17,691,621. 0.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

ISRG has been the subject of a number of research reports. Bernstein Bank boosted their price target on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Robert W. Baird dropped their price target on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 18th. JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. UBS Group increased their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. Finally, Raymond James boosted their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.